Seattle-area microbiome and diagnostics startup Viome Life Sciences is raising more cash, according to a new regulatory filing.
The filing shows $67 million raised of a larger round. We’ve reached out to Viome to learn more and will update when we hear back.
Viome sells a kit to determine the microbial composition of stool samples and recommends “precision” supplements and probiotics based on an individual’s readout. This July, the company released a “Full Body Intelligence Test” that also analyzes saliva and blood samples. Earlier this year celebrity and socialite Paris Hilton became a Viome brand ambassador.
The company is also developing a diagnostic test for oral and throat cancer that has received breakthrough device designation from the FDA, enabling it to receive expedited assessment prior to approval.
In April 2021, the six-year old company said it had more than 200,000 customers and was anticipating revenue to hit $100 million in 2022.
Viome is the seventh venture of founder and CEO Naveen Jain. Jain is the founder and former CEO of InfoSpace and also co-founded public records firm Intelius, as well as Moon Express, which aims to take paying customers to the moon.
Viome raised $54 million raised in November, bringing its total funding to more than $125 million.
Viome’s investors include Salesforce CEO Marc Benioff, Khosla Ventures, WestRiver Group, Glico, Physician Partners, Bold Capital Group and Ocgrow Ventures.
